Add to ORKGSystematic review In preterm infants with recurrent apnoea, methylxanthine reduces the number of episodes and the use of mechanical ventilation in the short term; caffeine is also associated with improved longer term outcome
Placebo-controlled trials have shown that caffeine is highly effective in treating apnoea of prematu...
Considerable uncertainty persists regarding the efficacy and safety of methylxanthines (caffeine, th...
The incidence of preterm birth is increasing, leading to a growing population with potential long-te...
Systematic review In preterm infants with recurrent apnoea, methylxanthine reduces the number of epi...
Background: Recurrent apnea is common in preterm infants, particularly at very early gestational age...
Background: Recurrent apnea is common in preterminfants, particularly at very early gestational ages...
Methylxanthines reduce the frequency of apnea of prematurity and the need for mechanical ventilation...
Infants who are born prematurely are at significant risk of apnoea. In addition to the short-term co...
Background Early administration of intravenous (IV) caffeine (initiation within 2 days of life) is a...
Caffeine, a methylxanthine and nonspecific inhibitor of adenosine receptors, is an example of a drug...
Infants who are born prematurely are at significant risk of apnoea. In addition to the short-term co...
Caffeine is a common treatment for neonatal intensive care management of the developmental complicat...
Summary: Apnea of prematurity (AOP) is a common problem that affects premature infants and, to a les...
Due to the importance of prevention of apnea of prematurity in the very preterm infants and the side...
The objective of the study is to determine if early high-dose caffeine (HD) therapy is associated wi...
Placebo-controlled trials have shown that caffeine is highly effective in treating apnoea of prematu...
Considerable uncertainty persists regarding the efficacy and safety of methylxanthines (caffeine, th...
The incidence of preterm birth is increasing, leading to a growing population with potential long-te...
Systematic review In preterm infants with recurrent apnoea, methylxanthine reduces the number of epi...
Background: Recurrent apnea is common in preterm infants, particularly at very early gestational age...
Background: Recurrent apnea is common in preterminfants, particularly at very early gestational ages...
Methylxanthines reduce the frequency of apnea of prematurity and the need for mechanical ventilation...
Infants who are born prematurely are at significant risk of apnoea. In addition to the short-term co...
Background Early administration of intravenous (IV) caffeine (initiation within 2 days of life) is a...
Caffeine, a methylxanthine and nonspecific inhibitor of adenosine receptors, is an example of a drug...
Infants who are born prematurely are at significant risk of apnoea. In addition to the short-term co...
Caffeine is a common treatment for neonatal intensive care management of the developmental complicat...
Summary: Apnea of prematurity (AOP) is a common problem that affects premature infants and, to a les...
Due to the importance of prevention of apnea of prematurity in the very preterm infants and the side...
The objective of the study is to determine if early high-dose caffeine (HD) therapy is associated wi...
Placebo-controlled trials have shown that caffeine is highly effective in treating apnoea of prematu...
Considerable uncertainty persists regarding the efficacy and safety of methylxanthines (caffeine, th...
The incidence of preterm birth is increasing, leading to a growing population with potential long-te...